XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Aug. 31, 2024
Aug. 31, 2023
Cash flows from operating activities:    
Net income $ 464,413 $ 439,875
Adjustments to reconcile net income to net cash provided by operating activities:    
Equity in income of unconsolidated joint ventures (22,654) (9,975)
Distributions of earnings from unconsolidated joint ventures 21,275 12,172
Amortization of debt issuance costs and premiums 2,602 2,525
Depreciation and amortization 28,259 26,986
Deferred income taxes 5,700 14,900
Gain on sale of investment (12,516) 0
Stock-based compensation 25,252 23,934
Inventory impairments and land option contract abandonments 3,685 10,207
Changes in assets and liabilities:    
Receivables 6,205 (1,581)
Inventories (504,436) 355,280
Accounts payable, accrued expenses and other liabilities (14,405) (100,486)
Other, net (3,299) (1,314)
Net cash provided by operating activities 81 772,523
Cash flows from investing activities:    
Contributions to unconsolidated joint ventures (12,611) (23,461)
Return of investments in unconsolidated joint ventures 1,992 5,100
Proceeds from sale of investment 1,709 0
Purchases of property and equipment, net (29,228) (26,412)
Net cash used in investing activities (38,138) (44,773)
Cash flows from financing activities:    
Borrowings under revolving credit facility 0 170,000
Repayments under revolving credit facility 0 (320,000)
Payments on mortgages and land contracts due to land sellers and other loans (2,822) (3,188)
Issuance of common stock under employee stock plans 9,272 8,608
Stock repurchases (250,000) (249,588)
Tax payments associated with stock-based compensation awards (16,505) (9,748)
Payments of cash dividends (53,537) (41,635)
Net cash used in financing activities (313,592) (445,551)
Net increase (decrease) in cash and cash equivalents (351,649) 282,199
Cash and cash equivalents at beginning of period 727,342 330,198
Cash and cash equivalents at end of period $ 375,693 $ 612,397